The market size of Atrial Flutter is anticipated to increase during the study period, 2018 – 2030 in the 7MM

Atrial Flutter Market

DelveInsight’s Atrial Flutter Market report provides an in-depth understanding of Atrial Flutter, historical and forecasted epidemiology, as well as Atrial Flutter market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The report also examines current Atrial Flutter treatment practices/algorithms, market drivers, market barriers, and unmet medical needs in order to identify and evaluate the market’s underlying potential.

Some Key Highlights from the Atrial Flutter Market Report

• Atrial flutter is the second most frequent cardiac arrhythmia after Atrial Fibrillation, according to Ziccardi et al. (2020). Males are more likely than females to experience Atrial Flutter. A higher incidence of Atrial Fibrillation and Atrial Flutter is linked to getting older.

• According to the Global Health Data Exchange, around 8 out of 10 persons suffering or diagnosed with Atrial Fibrillation or Atrial Flutter are found to be 65 years old or older in age.

• AcQBlate Force Sensing Ablation System (Acutus Medical) and Gencaro (ARCA Biopharma) are the emerging therapies in the Atrial Flutter market.

• Acutus Medical, ARCA Biopharma, Abbott, Adagio Medical, among others are the major companies involved in the Atrial Flutter market.

For more information request sample @ Atrial Flutter Market Insights

Atrial Flutter market report include current treatment methods, developing medications, Atrial Flutter market share of individual therapies, current and anticipated Atrial Flutter market size from 2018 to 2030 segmented by seven major markets.

Atrial Flutter: Disease Overview

Atrial Flutter is an arrhythmia in which the heart beats irregularly. Atrial Flutter is referred to as supraventricular (above the ventricles) tachycardia because it originates in the atria. The upper chambers of the heart (atria) beat too fast in Atrial Flutter. The heart beats faster, but normally in a steady rhythm as a result of this. It has a fast heart rate of 250-400 beats per minute.

Atrial Flutter Epidemiology Segmentation

• Atrial Flutter Total Incident Cases

• Atrial Flutter Total Incident Cases Segmented by Age

• Atrial Flutter Total Incident Cases Segmented by Gender

• Atrial Flutter Total Treated Cases

Atrial Flutter Treatment Landscape

The most important goal of treatment is to get the patient’s heart rate back to normal. The treatment for Atrial Flutter is determined on the cause, the patient’s symptoms, and the risk of stroke. The current treatment options for Atrial Flutter are:

• Cardioversion

• Ablation

• Anti-arrhythmic

• Calcium channel blockers

• Beta-blockers

Atrial Flutter Market

The growing senior population and increased incidence of Atrial Flutter in the 7MM have resulted in an increase in Atrial Flutter market size.

Key pharmaceutical companies such as Acutus Medical, ARCA Biopharma, Abbott, Adagio Medical, and others are expected to launch new therapies in the Atrial Flutter market.

Learn more about atrial flutter @ Atrial Flutter Treatment Landscape and Market Outlook

Atrial Flutter Pipeline Therapies

• AcQBlate Force Sensing Ablation System: Acutus Medical

• Gencaro: ARCA Biopharma

Atrial Flutter Major Companies

• Acutus Medical

• ARCA Biopharma

• Abbott

• Adagio Medical

Atrial Flutter Market Drivers

• Upsurge in the number of incident cases of Atrial Flutter

• Increase in aging population

Atrial Flutter Market Barriers

• Limited knowledge of Atrial Flutter

• Currently more focus on Atrial Fibrillation rather than Atrial Flutter

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)

Study Period: 2018-30

Atrial Flutter Key Companies: Acutus Medical, ARCA Biopharma, Abbott, Adagio Medical, among others. 

Atrial Flutter Key Pipeline Therapies: AcQBlate Force Sensing Ablation System (Acutus Medical) and Gencaro (ARCA Biopharma), and others.

Table of Contents 

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts

Related Reports

Atrial Fibrillation Market

Get comprehensive historical and forecast analysis of Atrial Fibrillation Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic plc, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc., among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/